Related Experiment Video
Updated: Aug 30, 2026
Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
Low-dose doxycycline prevents inflammatory bone resorption in rats
M M Bezerra1, G A C Brito, R A Ribeiro
1Departamento de Fisiologia e Farmacologia, Faculdade de Medicina, Universidade Federal do Ceará, Rua Cel. Nunes de Melo 1127, 60430-270 Fortaleza, CE, Brazil.
Abstract:
Matrix metalloproteinases (MMP) are considered to be key initiators of collagen degradation, thus contributing to bone resorption in inflammatory diseases. We determined whether subantimicrobial doses of doxycycline (DX) (< or =10 mg kg-1 day-1), a known MMP inhibitor, could inhibit bone resorption in an experimental periodontitis model. Thirty male Wistar rats (180-200 g) were subjected to placement of a nylon thread ligature around the maxillary molars and sacrificed after 7 days. Alveolar bone loss (ABL) was measured macroscopically in one hemiarcade and the contralateral hemiarcade was processed for histopathologic analysis. Groups of six animals each were treated with DX (2.5, 5 or 10 mg kg-1 day-1, sc, 7 days) and compared to nontreated (NT) rats. NT rats displayed significant ABL, severe mononuclear cell influx and increase in osteoclast numbers, which were significantly reduced by 5 or 10 mg kg-1 day-1 DX. These data show that DX inhibits inflammatory bone resorption in a manner that is independent of its antimicrobial properties.
Insights
Subantimicrobial doxycycline doses inhibit bone resorption in experimental periodontitis. This doxycycline effect on inflammatory bone loss is independent of its antimicrobial properties, offering potential therapeutic benefits.
Area of Science:
- Biomedical Science
- Oral Biology
- Pharmacology
Background:
- Matrix metalloproteinases (MMPs) are crucial in collagen degradation and bone resorption during inflammatory conditions.
- Periodontitis is characterized by inflammation leading to significant alveolar bone loss.
Purpose of the Study:
- To investigate the efficacy of subantimicrobial doxycycline (DX) doses in inhibiting bone resorption in an experimental periodontitis model.
- To determine if DX's inhibitory effect on bone resorption is independent of its antimicrobial activity.
Main Methods:
- An experimental periodontitis model was established in Wistar rats using a nylon thread ligature.
- Rats were treated with varying doses of doxycycline (2.5, 5, or 10 mg kg-1 day-1) or left untreated.
- Alveolar bone loss was assessed macroscopically and histopathologically.
Main Results:
- Untreated rats exhibited significant alveolar bone loss, increased mononuclear cell infiltration, and elevated osteoclast numbers.
- Doxycycline treatment at 5 and 10 mg kg-1 day-1 significantly reduced alveolar bone loss and associated inflammatory markers.
- Histopathological analysis confirmed reduced osteoclast activity in doxycycline-treated groups.
Conclusions:
- Subantimicrobial doses of doxycycline effectively inhibit inflammatory bone resorption in experimental periodontitis.
- The bone-resorption inhibitory effects of doxycycline in this model are not mediated by its antimicrobial properties.
- Doxycycline demonstrates potential as a therapeutic agent for managing inflammatory bone loss in periodontal diseases.
More Related Videos
04:24Proper Positioning and Restraint of a Rat Hind Limb for Focused High Resolution Imaging of Bone Micro-architecture Using In Vivo Micro-computed Tomography
Published on: November 22, 2017
07:20Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024